Antifungal Susceptibility to Amphotericin B, Fluconazole, Voriconazole, and Flucytosine in Candida Bloodstream Isolates from 15 Tertiary Hospitals in Korea.
10.3343/alm.2012.32.6.426
- Author:
Sook In JUNG
1
;
Jong Hee SHIN
;
Hyun Jung CHOI
;
Min Young JU
;
Soo Hyun KIM
;
Wee Gyo LEE
;
Yeon Joon PARK
;
Kyungwon LEE
Author Information
1. Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
- Publication Type:Brief Communication
- Keywords:
Candida;
Amphotericin B;
Flucytosine;
Fluconazole;
Voriconazole
- From:Annals of Laboratory Medicine
2012;32(6):426-428
- CountryRepublic of Korea
- Language:English
-
Abstract:
The in vitro antifungal susceptibility of 636 Candida bloodstream isolates collected from 15 tertiary hospitals in Korea was determined using the Vitek-2 yeast susceptibility system (bioMerieux, France). Overall susceptibility rates were 98.1%, 95.9%, 99.1%, and 97.3% for amphotericin B, fluconazole, voriconazole, and flucytosine, respectively. The results show that the rates of resistance to 4 antifungal drugs remain low among Candida bloodstream isolates in Korea.
